These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 5447246)
41. [Use of Staphylococcus aureus mutants in the search for antineoplastic antibiotics of Actinomycetes origin]. Kochetkova GV; Il'chenko GB; Kovsharova IN; Rossolimo OK; Proshliakova VV Antibiotiki; 1969 Oct; 14(10):900-3. PubMed ID: 5355860 [No Abstract] [Full Text] [Related]
42. Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines. Mordarski M; Chylińska B; Urbański T Arch Immunol Ther Exp (Warsz); 1970; 18(6):679-99. PubMed ID: 5493086 [No Abstract] [Full Text] [Related]
43. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice]. Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206 [TBL] [Abstract][Full Text] [Related]
44. [Production conditions and properties of the new antineoplastic antibiotic No. 294]. Brazhnikova MG; Kudinova MK; Vishniakova IA; Gauze GF; Preobrazhenskaia TP Antibiotiki; 1970 Aug; 15(8):675-8. PubMed ID: 5537044 [No Abstract] [Full Text] [Related]
45. Preclinical studies with vinglycinate, one of a series of chemically derived analogs of vinblastine. Johnson IS; Hargrove WW; Harris PN; Wright HF; Boder GB Cancer Res; 1966 Dec; 26(12):2431-6. PubMed ID: 5955595 [No Abstract] [Full Text] [Related]
46. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
47. [The antitumour action and toxicity of the alkaloidal fraction AC-875 from Catharanthus roseus]. Chang SY; Mao BY; Hsu B Yao Xue Xue Bao; 1965 Dec; 12(12):772-7. PubMed ID: 5898964 [No Abstract] [Full Text] [Related]
48. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations. Csányi E; Halász M Arzneimittelforschung; 1973 Jul; 23(7):961-7. PubMed ID: 4356189 [No Abstract] [Full Text] [Related]
54. [The use of tumor cells for the primary screening of antineoplastic antibiotics]. Ivanitskaia LP; Makukho LV Antibiotiki; 1969; 14(3):221-5. PubMed ID: 5409249 [No Abstract] [Full Text] [Related]
55. The evaluation of antitumor properties of acridine derivatives on the basis of the results from some in vivo and in vitro tests. Radzikowski C; Ledóchowski Z; Ledóchowski A; Wrzolek S; Hrabowska M; Konopa J Arch Immunol Ther Exp (Warsz); 1967; 15(1):126-8. PubMed ID: 6048222 [No Abstract] [Full Text] [Related]
56. [Cytotoxic changes in the nucleic acid content in a culture of tumor and normal cells as affected by a complex preparation from Bacillus mesentericus AB-56]. Khomiak OG; Volynets AK; Gushcha KP Mikrobiol Zh (1978); 1981; 43(5):650-6. PubMed ID: 6171711 [No Abstract] [Full Text] [Related]
57. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180]. Jugstand W; Gutsche W; Wiangke H Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431 [No Abstract] [Full Text] [Related]
58. [Fatty acids as possible antitumor agents]. Bogoslovskaia EP Izv Akad Nauk SSSR Biol; 1976; (3):440-8. PubMed ID: 780394 [No Abstract] [Full Text] [Related]
60. Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside. Paterson AR; Wang MC Cancer Res; 1970 Sep; 30(9):2379-87. PubMed ID: 4319905 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]